PMC:7464116 / 83671-84026 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T432","span":{"begin":18,"end":20},"obj":"Body_part"},{"id":"T433","span":{"begin":34,"end":42},"obj":"Body_part"},{"id":"T434","span":{"begin":255,"end":259},"obj":"Body_part"}],"attributes":[{"id":"A432","pred":"fma_id","subj":"T432","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A433","pred":"fma_id","subj":"T433","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A434","pred":"fma_id","subj":"T434","obj":"http://purl.org/sig/ont/fma/fma256135"}],"text":"Tocilizumab (anti-IL-6 monoclonal antibody) has been used in association with steroids and/or antiviral drugs, for the treatment of more severe clinical cases and patients with rapidly and significantly increasing levels of D-dimer. The dosage is 8 mg/kg body weight with a maximum infusion dose of 800 mg for a maximum of three administrations [154,155]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T934","span":{"begin":44,"end":47},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T935","span":{"begin":272,"end":273},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T936","span":{"begin":310,"end":311},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Tocilizumab (anti-IL-6 monoclonal antibody) has been used in association with steroids and/or antiviral drugs, for the treatment of more severe clinical cases and patients with rapidly and significantly increasing levels of D-dimer. The dosage is 8 mg/kg body weight with a maximum infusion dose of 800 mg for a maximum of three administrations [154,155]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T53955","span":{"begin":18,"end":20},"obj":"Chemical"},{"id":"T59409","span":{"begin":78,"end":86},"obj":"Chemical"},{"id":"T40321","span":{"begin":94,"end":109},"obj":"Chemical"},{"id":"T35540","span":{"begin":94,"end":103},"obj":"Chemical"},{"id":"T69824","span":{"begin":104,"end":109},"obj":"Chemical"}],"attributes":[{"id":"A81642","pred":"chebi_id","subj":"T53955","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A5405","pred":"chebi_id","subj":"T53955","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A74367","pred":"chebi_id","subj":"T59409","obj":"http://purl.obolibrary.org/obo/CHEBI_35341"},{"id":"A93428","pred":"chebi_id","subj":"T40321","obj":"http://purl.obolibrary.org/obo/CHEBI_36044"},{"id":"A46905","pred":"chebi_id","subj":"T35540","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A98612","pred":"chebi_id","subj":"T69824","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Tocilizumab (anti-IL-6 monoclonal antibody) has been used in association with steroids and/or antiviral drugs, for the treatment of more severe clinical cases and patients with rapidly and significantly increasing levels of D-dimer. The dosage is 8 mg/kg body weight with a maximum infusion dose of 800 mg for a maximum of three administrations [154,155]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T501","span":{"begin":0,"end":232},"obj":"Sentence"},{"id":"T502","span":{"begin":233,"end":355},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Tocilizumab (anti-IL-6 monoclonal antibody) has been used in association with steroids and/or antiviral drugs, for the treatment of more severe clinical cases and patients with rapidly and significantly increasing levels of D-dimer. The dosage is 8 mg/kg body weight with a maximum infusion dose of 800 mg for a maximum of three administrations [154,155]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2484","span":{"begin":18,"end":22},"obj":"Gene"},{"id":"2485","span":{"begin":163,"end":171},"obj":"Species"},{"id":"2486","span":{"begin":0,"end":11},"obj":"Chemical"},{"id":"2487","span":{"begin":78,"end":86},"obj":"Chemical"}],"attributes":[{"id":"A2484","pred":"tao:has_database_id","subj":"2484","obj":"Gene:3569"},{"id":"A2485","pred":"tao:has_database_id","subj":"2485","obj":"Tax:9606"},{"id":"A2486","pred":"tao:has_database_id","subj":"2486","obj":"MESH:C502936"},{"id":"A2487","pred":"tao:has_database_id","subj":"2487","obj":"MESH:D013256"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Tocilizumab (anti-IL-6 monoclonal antibody) has been used in association with steroids and/or antiviral drugs, for the treatment of more severe clinical cases and patients with rapidly and significantly increasing levels of D-dimer. The dosage is 8 mg/kg body weight with a maximum infusion dose of 800 mg for a maximum of three administrations [154,155]."}

{"project":"2_test","denotations":[{"id":"32759645-32234467-58096288","span":{"begin":346,"end":349},"obj":"32234467"},{"id":"32759645-32376398-58096289","span":{"begin":350,"end":353},"obj":"32376398"}],"text":"Tocilizumab (anti-IL-6 monoclonal antibody) has been used in association with steroids and/or antiviral drugs, for the treatment of more severe clinical cases and patients with rapidly and significantly increasing levels of D-dimer. The dosage is 8 mg/kg body weight with a maximum infusion dose of 800 mg for a maximum of three administrations [154,155]."}